You are here: Home » Companies » News
Business Standard

Lupin to launch sleep disorder drug in US

US business contributes over 40 per cent to the company revenue

Aneesh Phadnis  |  Mumbai: 

Lupin to launch sleep disorder drug in US

is launching generic version of Nuvigil tablets in the market. The brand has an annual market size of $515 million and is the third company to launch the generic version in the US.

On Tuesday announced it had received the Food and Administration department's final approval for the product and is launching the product shortly. The product was filed from the company's Goa plant which recently received clearance from the regulator.

business contributes over 40 per cent to the company revenue. In the first half, the business grew to 78 per cent to Rs 4,186 crore on a year on year basis. The results include the contribution of firm Gavis which the company acquired earlier this year.

has so far launched five products in the market in current fiscal and has received 16 product approvals in the same period.

RECOMMENDED FOR YOU

Lupin to launch sleep disorder drug in US

US business contributes over 40 per cent to the company revenue

US business contributes over 40 per cent to the company revenue

is launching generic version of Nuvigil tablets in the market. The brand has an annual market size of $515 million and is the third company to launch the generic version in the US.

On Tuesday announced it had received the Food and Administration department's final approval for the product and is launching the product shortly. The product was filed from the company's Goa plant which recently received clearance from the regulator.

business contributes over 40 per cent to the company revenue. In the first half, the business grew to 78 per cent to Rs 4,186 crore on a year on year basis. The results include the contribution of firm Gavis which the company acquired earlier this year.

has so far launched five products in the market in current fiscal and has received 16 product approvals in the same period.

image
Business Standard
177 22

Lupin to launch sleep disorder drug in US

US business contributes over 40 per cent to the company revenue

is launching generic version of Nuvigil tablets in the market. The brand has an annual market size of $515 million and is the third company to launch the generic version in the US.

On Tuesday announced it had received the Food and Administration department's final approval for the product and is launching the product shortly. The product was filed from the company's Goa plant which recently received clearance from the regulator.

business contributes over 40 per cent to the company revenue. In the first half, the business grew to 78 per cent to Rs 4,186 crore on a year on year basis. The results include the contribution of firm Gavis which the company acquired earlier this year.

has so far launched five products in the market in current fiscal and has received 16 product approvals in the same period.

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard